Abstract
A minimal approach to risk assessment in reproductive toxicology involves four components: hazard identification, hazard characterization, exposure characterization, and risk characterization. In practice, risk assessment in reproductive toxicology has been reduced to arbitrary safety factors or mathematical models of the dose-response relationship. These approaches obscure biological differences across species rather than using this important and frequently accessible information. Two approaches that are formally capable of using biologically relevant information (pharmacokinetics and expert system shells) are explored as aids to risk assessment in reproductive toxicology.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Frankos V. H. FDA perspectives on the use of teratology data for human risk assessment. Fundam Appl Toxicol. 1985 Aug;5(4):615–625. doi: 10.1016/0272-0590(85)90185-x. [DOI] [PubMed] [Google Scholar]
- Gerhardsson L., Ahlmark A. Silicosis in women. Experience from the Swedish Pneumoconiosis Register. J Occup Med. 1985 May;27(5):347–350. [PubMed] [Google Scholar]
- Slikker W., Jr, Hill D. E., Young J. F. Comparison of the transplacental pharmacokinetics of 17 beta-estradiol and diethylstilbestrol in the subhuman primate. J Pharmacol Exp Ther. 1982 Apr;221(1):173–182. [PubMed] [Google Scholar]
- Smith M. K., Kimmel G. L., Kochhar D. M., Shepard T. H., Spielberg S. P., Wilson J. G. A selection of candidate compounds for in vitro teratogenesis test validation. Teratog Carcinog Mutagen. 1983;3(6):461–480. doi: 10.1002/1520-6866(1990)3:6<461::aid-tcm1770030603>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]